US 11986449
Levodopa dosing regimen
granted A61KA61K31/198A61K9/4825
Quick answer
US patent 11986449 (Levodopa dosing regimen) held by AMNEAL PHARMACEUTICALS LLC expires Mon May 16 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- AMNEAL PHARMACEUTICALS LLC
- Grant date
- Tue May 21 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 16 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 17
- CPC classes
- A61K, A61K31/198, A61K9/4825, A61K9/5005, A61K9/5026